← Back to Newsletter Archive

Greetings!

Welcome to the Monthly QPS Preclinical Newsletter


Discover more about QPS' proprietary GLP-1 and IgG assays, learn more about biotransformation studies, and catch up on the latest scientific insights and breakthroughs on the QPS Blog.

QPS Proprietary GLP-1 and IgG Assays

GLP-1 receptor agonists are now among the fastest-growing therapeutic classes, with semaglutide supporting an expanding range of clinical programs. Our lab offers a proprietary semaglutide assay designed for accurate, reproducible bioanalysis across development stages.



Accurate pharmacokinetic profiling of monoclonal antibodies via LC-MS/MS bioanalysis is critical for dose selection and safety assessment. Our proprietary IgG 1 and IgG 4 assays deliver robust quantification across the full PK curve, supporting accurate exposure assessment.

Ensure Safer Medicine with QPS Biotransformation Expertise

QPS conducts specialized preclinical biotransformation studies in its US DMPK labs, providing critical insights into metabolism, enzyme activity, drug-drug interactions, and bioavailability to help developers ensure safer, more effective drug candidates before human trials.


QPS biotransformation studies determine how a molecule may be altered by the action of enzymes. QPS studies include in vitro metabolic stability, in vitro comparison of metabolite formation, in vivo metabolite profiling, identification and quantification.


Contact Us to learn more

Download the White Paper

Therapeutic Oligonucleotide Metabolite Identification, Profiling and Quantitation

Discover the Future of Science on the QPS Blog

Enzyme of Death Kills Cancer Cells

 

Today’s cancer drugs are more sophisticated and accessible than ever before. But unfortunately, cancer drug resistance remains a life-threatening challenge for...



Targeting Stubborn Cancer Cells

Oncology Services at QPS

Scalable Kelp Farming Could Spur a New Wave of Medical Innovation?

 

Kelp farming promises a rare combination of environmental benefit and economic opportunity. Researchers are investigating kelp and other seaweeds for….

 

Testing the Limits Offshore

See More Therapy Area Blog Posts

Contact the Experts at QPS

 

Request a meeting with QPS preclinical, bioanalysis, translational medicine, and/or clinical research subject matter experts today. 

Visit our website www.qps.com 

or contact us at infopr@qps.com

to start your next study.

Linkedin  Youtube  X  Facebook

View as Webpage

www.qps.cominfopr@qps.com

We use your email address exclusively for sending QPS newsletters with a special e-mail program. If you no longer wish to receive any mailings, simply use the "unsubscribe" link at the bottom. If you don't unsubscribe, we assume that this consent also applies to the system of the GDPR. (Data protection notice: According to Art. 7 GDPR, the consent can of course also be withdrawn at any time after May 25, 2018.)
← Back to Newsletter Archive